Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...
Driven by obesity and acid reflux, esophageal cancer has become the fastest rising cancer in Caucasian men in the United States. The thoracic oncologists and gastroenterologists at the Baylor St. Luke ...
Merck and Japan-based Eisai said on Friday a combination of their therapies failed to extend the lives of patients with a type of esophageal cancer in a late-stage trial. The trial was studying U.S.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果